Daridorexant
Daridorexant
Daridorexant (pronounced dah-ri-doh-rex-ant) is a novel dual orexin receptor antagonist (DORA) developed for the treatment of insomnia.
Etymology
The name "Daridorexant" is derived from the combination of the words "dual", "orexin", and "antagonist", referring to its mechanism of action. The suffix "-ant" is commonly used in pharmacology to denote a substance that inhibits or counteracts another.
Mechanism of Action
Daridorexant works by blocking the orexin neurotransmitter system, which is known to play a key role in arousal and wakefulness. By inhibiting the action of orexin, Daridorexant promotes sleep.
Related Terms
- Dual orexin receptor antagonist (DORA): A class of drugs that inhibit the action of orexin, a neurotransmitter involved in arousal and wakefulness.
- Insomnia: A sleep disorder characterized by difficulty falling asleep, staying asleep, or both.
- Orexin: A neurotransmitter that regulates arousal, wakefulness, and appetite.
See Also
External links
- Medical encyclopedia article on Daridorexant
- Wikipedia's article - Daridorexant
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski